Post-menopausal and ovariectomized women have a higher risk for cardiovascular disease compared to pre-menopausal women. This decreased risk has been attributed to the beneficial effects of estrogen in premenopausal women and estrogen replacement therapy in post-menopausal woman. Therefore, understanding how estrogen protects against cardiovascular disease is an important problem, not only in women but also in men. Estrogen is a potent vasodilator, and previous studies indicate that estrogen's vasodilatory effect is mediated by endothelium-derived nitric oxide (NO). NO inhibits platelet aggregation, vascular smooth muscle proliferation, and leukocyte adhesion to the vascular wall. Indeed, recent studies suggest that some of estrogen's cardiovascular protective effects are mediated by its stimulatory effects on endothelial nitric oxide synthase (eNOS). Therefore, understanding how estrogen activates eNOS may provide important new insights into some of the rapid molecular actions of estrogen. We have recently reported that estrogen stimulates eNOS activity via the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway. Interestingly, we found that the estrogen receptor (ER) isoform, ERalpha, interacts with the p85alpha regulatory subunit of PI3K in a ligand-dependent manner. Based upon these initial findings, we now propose to determine the subcellular localization of ERa by confocal microscopy; colocalize ERa and p85a using fluorescent resonance energy transfer (FRET); and to identify the putative interaction domain(s) of ERalpha and p85alpha. We then propose to study the physiological significance of this interaction by """"""""knocking in"""""""" the mutated ERalpha or p85alpha, which cannot interact with each other, and then to determine whether eNOS activation by estrogen is impaired in these mice. The relevance of this pathway will be further tested in models of vascular injury and ischemic stroke where estrogen and NO have been shown to be protective. The generation of these mice may also be useful in studying the """"""""nuclear"""""""" versus """"""""non-nuclear"""""""" effects of estrogen in other non-vascular tissues such as bone. The significance of the proposed studies is that by linking the ER to PI3K, a potential critical step in the non-nuclear action of estrogen is suggested and the role of ER is considerably broadened since PI3K is known to mediate diverse cellular functions. These results may explain some of the actions of selective estrogen receptor modulators (SERMs) and provide a therapeutic basis for using estrogens in cardiovascular disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK062729-05
Application #
7191674
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Margolis, Ronald N
Project Start
2003-06-01
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2009-04-30
Support Year
5
Fiscal Year
2007
Total Cost
$351,650
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Sawada, Naoki; Liao, James K (2014) Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Antioxid Redox Signal 20:1251-67
Tanaka, Shin-ichi; Fukumoto, Yoshihiro; Nochioka, Kotaro et al. (2013) Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol 33:1591-600
Montalvo, J; Spencer, C; Hackathorn, A et al. (2013) ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. Curr Mol Med 13:205-19
Liao, James K (2012) Mitohormesis: another pleiotropic effect of statins? Eur Heart J 33:1299-301
Hung, Ming-Jui; Cherng, Wen-Jin; Hung, Ming-Yow et al. (2012) Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. Atherosclerosis 221:521-6
Wang, Chao-Yung; Liao, James K (2012) A mouse model of diet-induced obesity and insulin resistance. Methods Mol Biol 821:421-33
Zhou, Qian; Mei, Yu; Shoji, Takuhito et al. (2012) Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis. Circulation 126:2236-47
Wang, Qing Mei; Stalker, Timothy J; Gong, Yulan et al. (2012) Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Vasc Med 17:379-85
Zhou, Qian; Gensch, Christoph; Liao, James K (2011) Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 32:167-73
Hata, Takaki; Goto, Chikara; Soga, Junko et al. (2011) Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil. Atherosclerosis 214:117-21

Showing the most recent 10 out of 84 publications